Recall Register

Food, drugs, devices › AbbVie Inc.

Drug recall: Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distribut

FDA enforcement event 95332 · Class II · initiated 16 Sep 2024 · status Ongoing

DrugVoluntary: Firm initiated2 product recordsNorth Chicago, IL

FDA enforcement event 95332 is a drug recall by AbbVie Inc. of North Chicago, IL, initiated 16 Sep 2024 and classified Class II, with 2 product records.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 71% of the 319 drug enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. AbbVie Inc. has 12 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

AbbVie Inc., North Chicago, IL.

Reason for recall

"Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal."

Distribution

"Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)"

Product records

Recall numberProductQuantityClassStatusReport date
D-0664-2024Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230667043,2,473,563 tubesClass IIOngoing2 Oct 2024
D-0665-2024Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230312042763,426 tubesClass IIOngoing2 Oct 2024

Context

71%of 2024 drug events are Class II319 events that year
2product records in this eventfirm median: 1
12events on this register for the firm

Other enforcement events for AbbVie Inc.

InitiatedProduct (first record)TypeClassRecords
18 May 2026PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie coDrugClass III1
17 Oct 2023Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 6DrugClass III1
22 Jan 2018Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USADrugClass III1
8 Sep 2017AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pumpDrugClass III2
27 Apr 2017AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.DeviceClass II3
13 Jan 2017Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx OnlDrugClass II1
22 Nov 2016AbbVie PEG Kit 20 FRDeviceClass II1
24 Mar 2016Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-DrugClass III1
15 Sep 2014CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbViDrugClass II1
10 Mar 2014Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringDrugClass II5

All 12 events for AbbVie Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.